AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • September 14th, 2023 • Harmony Biosciences Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 14th, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of August 14, 2023, by and among: Harmony Biosciences Holdings, Inc., a Delaware corporation (“Parent”); Xylophone Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”); and Zynerba Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1.1.